Immunovant Cash Flow Statement
NASDAQ: IMVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
30.47+0.21 (+0.69%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Immunovant free cash flow
In fiscal 2026, Immunovant generated -$407.3 million of operating cash flow and spent $8,000 on capital expenditures. That left free cash flow of -$407.3 million.
Summary generated from market data by MetaCap's automated system. Methodology
Immunovant cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20202021-03-31 | FY 20192020-03-31 | FY 20192019-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -505.61M | -413.84M | -259.34M | -210.96M | -156.73M | -107.43M | -66.39M | -28.60M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 409.00K | 377.00K | 231.00K | 193.00K | 126.00K | 65.00K | 21.00K | 10.00K |
| Stock-Based Compensation | 55.72M | 49.49M | 41.12M | 32.30M | 34.24M | 18.82M | 6.96M | 1.31M |
| Change in Working Capital | 35.73M | 22.84M | 2.56M | 10.21M | 14.09M | 5.12M | 7.47M | 3.98M |
| Operating Cash Flow | -407.31M | -375.87M | -214.23M | -188.19M | -106.11M | -83.33M | -53.36M | -28.55M |
| Capital Expenditures | -8.00K | -759.00K | -360.00K | -197.00K | -254.00K | -210.00K | -31.00K | -52.00K |
| Investing Cash Flow | -8.00K | -759.00K | -360.00K | -197.00K | -254.00K | -210.00K | -31.00K | -52.00K |
| Financing Cash Flow | 595.76M | 454.49M | 472.43M | 70.89M | 200.13M | 383.11M | 146.97M | 35.58M |
| Net Change in Cash | 188.14M | 78.61M | 258.83M | -117.28M | 93.67M | 299.57M | 93.59M | 6.99M |
| Free Cash Flow | -407.32M | -376.63M | -214.59M | -188.39M | -106.37M | -83.54M | -53.39M | -28.60M |
This table shows 8 annual periods of Immunovant's cash flow statement, from FY 2026 back to FY 2019, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IMVT's reporting calendar. What is a cash flow statement?